Evidence map›Paper›PMID 35175176›Full record

ArticlePharmaceutical biology2022

Cyanidin attenuates the apoptosis of rat nucleus pulposus cells and the degeneration of intervertebral disc via the JAK2/STAT3 signal pathway

Xiaoliang Bai, Meichao Jiang, Jie Wang, Shuai Yang, Zhiwei Liu, Hongxin Zhang, Xiaojuan Zhu

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xiaoliang BaiDepartment of Orthopaedics, Baoding NO.1 Central Hospital, Baoding, China.
Meichao JiangDepartment of Orthopaedics, Baoding NO.1 Central Hospital, Baoding, China.
Jie WangDepartment of Orthopaedics, Baoding NO.1 Central Hospital, Baoding, China.
Shuai YangDepartment of Orthopaedics, Baoding NO.1 Central Hospital, Baoding, China.
Zhiwei LiuDepartment of Orthopaedics, Baoding NO.1 Central Hospital, Baoding, China.
Hongxin ZhangDepartment of Orthopaedics, Baoding NO.1 Central Hospital, Baoding, China.
Xiaojuan ZhuDepartment of Geratology, Baoding NO.1 Central Hospital, Baoding, China.
Baoding People's Hospital · CNBaoding No.1 Central Hospital

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextCyanidin has been shown to have therapeutic potential in osteoarthritis. However, it is unclear whether cyanidin prevents the progression of intervertebral disc degeneration (IVDD).

objectiveThis study evaluates the effects of cyanidin on IVDD MATERIALS AND

methodsNucleus pulposus cells (NPCs) isolated from lumbar IVD of 4-week-old male Sprague-Dawley (SD) rats were exposed to 20 ng/mL IL-1β, and then treated with different doses (0-120 µM) of cyanidin for 24 h. SD rats were classified into three groups (

resultsThe IC DISCUSSION AND

conclusionsCyanidin improved the function of NPCs in IVDD by regulating the JAK2/STAT3 pathway, which may provide a novel alternative strategy for IVDD. The mechanism of cyanidin improving IVDD still needs further work for in-depth investigation.

Indexed as

AnimalsAnthocyaninsApoptosisDose-Response Relationship, DrugInhibitory Concentration 50Interleukin-1betaIntervertebral Disc DegenerationJanus Kinase 2MaleNucleus PulposusRatsRats, Sprague-DawleySignal TransductionSTAT3 Transcription FactorAnthocyaninscyanidinInterleukin-1betaJak2 protein, ratJanus Kinase 2Stat3 protein, ratSTAT3 Transcription FactorautophagychloroquineExtracellular matrix degenerationnatural polyphenolic compounds

Identifiers

PMID35175176
PMCPMC8856032
OpenAlexW4212929765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.